Spots Global Cancer Trial Database for thalidomide
Every month we try and update this database with for thalidomide cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | NCT00083681 | Multiple Myelom... | Thalidomide Dexamethasone Cytoxan Etoposide Cisplatin G-CSF | 18 Years - | University of Arkansas | |
| Home Treatment of HIV-Infected Patients With Interleukin-2 With or Without a Tumor Necrosis Factor Antagonist | NCT00001475 | Acquired Immuno... HIV Infection | IL-2 plus Anti-... | - | National Institutes of Health Clinical Center (CC) | |
| Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid Tumors | NCT01661400 | Glioma Neuroectodermal... Wilms Tumor Rhabdomyosarcom... Sarcoma, Ewing Osteosarcoma Retinoblastoma | Metronomic Cycl... Thalidomide | 6 Months - 21 Years | Washington University School of Medicine | |
| Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma | NCT00165217 | Colorectal Aden... | Capecitabine Thalidomide | 18 Years - | Dana-Farber Cancer Institute | |
| PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma | NCT00319865 | Multiple Myelom... | Velcade Thalidomide Adriamycin Dexamethasone | 0 Years - 75 Years | Korean Multiple Myeloma Working Party | |
| Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas | NCT00047879 | Glioma | PEG-interferon ... Thalidomide | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS | NCT02586038 | Multiple Myelom... | MLN9708 Dexamethasone Cyclophosphamid... Thalidomide | 65 Years - | University of Turin, Italy | |
| Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma | NCT00006890 | Multiple Myelom... | prednisone thalidomide | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Study in Myeloma Patients Newly Diagnosed Treated as an Induction With Velcade-Dex or Velcade (Bortezomib) Thalidomide Dexamethasone (VTD) | NCT00910897 | Multiple Myelom... | Velcade-Dexamet... Velcade-Thalido... | 18 Years - 65 Years | Intergroupe Francophone du Myelome | |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00047294 | Brain and Centr... | celecoxib temozolomide thalidomide adjuvant therap... | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant | NCT00003894 | Graft Versus Ho... Unspecified Adu... Unspecified Chi... | thalidomide | 3 Years - | Roswell Park Cancer Institute | |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00047294 | Brain and Centr... | celecoxib temozolomide thalidomide adjuvant therap... | 18 Years - 120 Years | Dana-Farber Cancer Institute | |
| Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer | NCT00038181 | Prostate Cancer | Thalidomide | - | M.D. Anderson Cancer Center | |
| THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) | NCT01341262 | Multiple Myelom... | Thalidomide Dexamethasone Zoledronic acid Cyclophosphamid... Melphalan | 18 Years - 65 Years | IRCCS Azienda Ospedaliero-Universitaria di Bologna | |
| EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide | NCT03341494 | NSCLC Stage IV Chemotherapy Ef... | Thalidomide | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis | NCT04612582 | Immunoglobulin ... | Thalidomide Cyclophosphamid... | 18 Years - 80 Years | Guangdong Provincial People's Hospital | |
| Interferon Alfa Plus Thalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | NCT00015912 | Recurrent Grade... Recurrent Grade... | recombinant int... thalidomide laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding | NCT00389935 | Arteriovenous M... Hereditary Hemo... Hematochezia Melena | Thalidomide | 18 Years - | Northport Veterans Affairs Medical Center | |
| Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed | NCT00006006 | Liver Cancer | recombinant int... thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Docetaxel and Thalidomide as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer | NCT00114192 | Lung Cancer | docetaxel thalidomide | 18 Years - | University of Virginia | |
| Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma | NCT00644306 | Newly Diagnosed... | Thalidomide melphalan, pred... melphalan, pred... | 75 Years - | Central Hospital, Nancy, France | |
| Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | NCT00215943 | Multiple Myelom... | zoledronic acid dexamethasone thalidomide vincristine adriamycin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | NCT02748772 | Colorectal Neop... | Two Anti-angiog... Pure chemothera... | 18 Years - 75 Years | The First People's Hospital of Hefei | |
| S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma | NCT00040937 | Multiple Myelom... | filgrastim sargramostim cyclophosphamid... dexamethasone melphalan prednisone thalidomide peripheral bloo... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| Lenalidomide, Thalidomide and Dexamethasone in Treating Participants With Relapsed or Refractory Multiple Myeloma | NCT00966693 | Recurrent Plasm... Refractory Plas... | Dexamethasone Lenalidomide Thalidomide | 18 Years - | M.D. Anderson Cancer Center | |
| A Study of Tegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine Tumor | NCT03204019 | Pancreatic Neur... | Tegafur and Tem... Tegafur and Tem... | 18 Years - | ChineseAMS | |
| Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT00602641 | Multiple Myelom... | Laboratory Biom... Lenalidomide Melphalan Prednisone Quality-of-Life... Thalidomide | 18 Years - | National Cancer Institute (NCI) | |
| Long-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165 | NCT02507336 | Mantle Cell Lym... Non-Hodgkin's L... | Thalidomide | 18 Years - | University of Miami | |
| Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus | NCT00025506 | Recurrent Uteri... Uterine Carcino... | Laboratory Biom... Thalidomide | - | National Cancer Institute (NCI) | |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00041080 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | tamoxifen citra... thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma | NCT00028886 | Multiple Myelom... | filgrastim recombinant int... cyclophosphamid... dexamethasone doxorubicin hyd... melphalan thalidomide vincristine sul... bone marrow abl... peripheral bloo... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
| Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases | NCT00033254 | Tumors Metastat... | radiation thera... thalidomide quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Application of Two Anti-angiogenesis Drugs Combined With Chemotherapy in Advanced Colorectal Cancer Under the Background of Precision Medical | NCT02748772 | Colorectal Neop... | Two Anti-angiog... Pure chemothera... | 18 Years - 75 Years | The First People's Hospital of Hefei | |
| Study of VTD in Waldenstrom's Macroglobulinemia | NCT03335098 | Waldenstrom Mac... Lymphoplasmacyt... | Bortezomib | 19 Years - | Seoul National University Hospital | |
| Velcade, Thalidomide, Dexamethasone and Panobinostat Treatment and Panobinostat Maintenance in Multiple Myeloma | NCT02145715 | Multiple Myelom... | Velcade Thalidomide Dexamethasone Panobinostat | 18 Years - | University of Leeds | |
| A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer | NCT00165451 | Neoplasms | Thalidomide Celecoxib Etoposide Cyclophosphamid... | - 21 Years | Dana-Farber Cancer Institute | |
| Thalidomide, Doxorubicin, and Dexamethasone in Treating Patients With Untreated Stage II or Stage III Multiple Myeloma | NCT00008242 | Multiple Myelom... | dexamethasone doxorubicin hyd... thalidomide | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer | NCT00001446 | Prostatic Neopl... | thalidomide | - | National Institutes of Health Clinical Center (CC) | |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | NCT00357500 | Central Nervous... Leukemia Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | celecoxib cyclophosphamid... etoposide fenofibrate thalidomide | - 21 Years | Dana-Farber Cancer Institute | |
| Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma | NCT00124813 | Multiple Myelom... | thalidomide idarubicin | 18 Years - | University Hospital, Bonn | |
| Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma | NCT01438450 | Hepatocellular ... | Oral Supportive | 12 Years - 70 Years | All India Institute of Medical Sciences, New Delhi | |
| Combination Therapy With 5-Fluorouracil, Interferon-an Interleukin-2, & Thalidomide for Metastatic, Advanced or Recurrent Renal Cell Carcinoma | NCT00277017 | Kidney Cancer | 5-Flourouracil,... | - | New Mexico Cancer Care Alliance | |
| S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma | NCT00005834 | Multiple Myelom... | filgrastim cisplatin cyclophosphamid... dexamethasone etoposide thalidomide | 18 Years - | SWOG Cancer Research Network | |
| Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer | NCT00038181 | Prostate Cancer | Thalidomide | - | M.D. Anderson Cancer Center | |
| EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide | NCT03341494 | NSCLC Stage IV Chemotherapy Ef... | Thalidomide | 18 Years - 70 Years | Fujian Cancer Hospital | |
| Radiation Therapy With or Without Thalidomide in Treating Patients With Brain Metastases | NCT00033254 | Tumors Metastat... | radiation thera... thalidomide quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor | NCT00006358 | Brain and Centr... | temozolomide thalidomide | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Radiotherapy Plus Thalidomide in Locally Advanced Hepatocellular Carcinoma | NCT00155272 | Hepatocellular ... | Thalidomide | 20 Years - 70 Years | National Taiwan University Hospital | |
| Combination Chemo, Peripheral Stem Cell Transplant, Biological Therapy, Pamidronate and Thalidomide for Multiple Myeloma | NCT00004088 | Multiple Myelom... | filgrastim recombinant int... busulfan cyclophosphamid... melphalan pamidronate dis... thalidomide peripheral bloo... | - 65 Years | City of Hope Medical Center | |
| Thalidomide in Treating Patients With Relapsed Chronic Lymphocytic Leukemia | NCT00006226 | B-cell Chronic ... Refractory Chro... | thalidomide laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma | NCT00112879 | Stage I Multipl... Stage II Multip... Stage III Multi... Refractory Plas... | arsenic trioxid... ascorbic acid dexamethasone thalidomide anti-cytokine t... antiangiogenesi... biological ther... chemotherapy drug resistance... growth factor a... non-specific im... | 18 Years - | National Cancer Institute (NCI) | |
| Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma | NCT00193544 | Multiple Myelom... | Arsenic Trioxid... Thalidomide | 18 Years - | SCRI Development Innovations, LLC | |
| A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors | NCT00251797 | Brain and Nervo... Cancer | Irinotecan Thalidomide | 18 Years - | University of New Mexico | |
| Thalidomide, Lenalidomide, and Rituximab for Previously Treated Waldenstrom Macroglobulinemia | NCT01779167 | Waldenstrom Mac... | Thalidomide Lenalidomide Rituximab | 18 Years - | Weill Medical College of Cornell University | |
| EDOCH Alternating With DHAP for New Diagnosed Younger MCL | NCT02858804 | Mantle Cell Lym... | Etoposide Doxorubicin Dexamethasone Vincristine Cyclophosphamid... Cytarabine Cisplatin Rituximab Thalidomide Prednisone | 18 Years - 65 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma | NCT02410694 | Multiple Myelom... | Ixazomib Thalidomide Dexamethasone | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| Effects of Exercise in Combination With Epoetin Alfa | NCT00577096 | Multiple Myelom... | Epoetin Alfa Exercise Autologous Peri... Red Blood Cell ... Thalidomide Heparin, Low-Mo... Platelet Transf... Melphalan Epoetin Alfa Total Therapy I... Red Blood Cell ... Thalidomide Heparin, Low-Mo... Platelet Transf... Melphalan | - | University of Arkansas | |
| Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) | NCT00307294 | Prostate Cancer | Thalidomide Doxil | 18 Years - | University of Pittsburgh | |
| GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer | NCT00400517 | Prostate Cancer | sargramostim thalidomide conventional su... neoadjuvant the... | - 120 Years | The Cleveland Clinic | |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00027638 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... | thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| Tamoxifen Compared With Thalidomide in Treating Women With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer | NCT00041080 | Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria... | tamoxifen citra... thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia | NCT00723658 | Lymphoma | rituximab bortezomib carmustine cisplatin cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide melphalan thalidomide autologous-auto... peripheral bloo... | 18 Years - | SWOG Cancer Research Network | |
| Thalidomide Plus Chemotherapy Versus Chemotherapy Alone for Advanced Breast Cancer | NCT02649101 | Metastatic Brea... | Thalidomide Physician's cho... | 18 Years - 65 Years | Zhejiang Cancer Hospital | |
| Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma | NCT01057225 | Multiple Myelom... Stage I Multipl... Stage II Multip... Stage III Multi... | carfilzomib cyclophosphamid... thalidomide dexamethasone | 18 Years - | Mayo Clinic | |
| S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia | NCT00723658 | Lymphoma | rituximab bortezomib carmustine cisplatin cyclophosphamid... cytarabine dexamethasone doxorubicin hyd... etoposide melphalan thalidomide autologous-auto... peripheral bloo... | 18 Years - | SWOG Cancer Research Network | |
| UARK 2003-33, Total Therapy III | NCT00081939 | Multiple Myelom... | Velcade Thalidomide | 18 Years - 75 Years | University of Arkansas | |
| Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma | NCT00644306 | Newly Diagnosed... | Thalidomide melphalan, pred... melphalan, pred... | 75 Years - | Central Hospital, Nancy, France | |
| The Efficacy of TCD Following by TP Maintenance Therapy in Newly Diagnosed WM | NCT02844309 | Waldenström Mac... | Thalidomide | 18 Years - 85 Years | Institute of Hematology & Blood Diseases Hospital, China | |
| Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) | NCT00075829 | Multiple Myelom... | One Autologous ... Non-Myeloablati... Second Autologo... Thalidomide Dexamethasone Observation | - 70 Years | National Heart, Lung, and Blood Institute (NHLBI) | |
| Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors | NCT00027638 | Gastrointestina... Islet Cell Tumo... Lung Cancer Neoplastic Synd... | thalidomide | - | Memorial Sloan Kettering Cancer Center | |
| Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma | NCT00049673 | Multiple Myelom... | prednisone thalidomide | 16 Years - | Canadian Cancer Trials Group | |
| Irinotecan Plus Thalidomide in Second Line Advanced Gastric Cancer | NCT02401971 | Gastric Cancer | Thalidomide CPT-11 | 18 Years - 75 Years | Zhengzhou University | |
| Conmana Combined With Thalidomide to Treat NSCLC | NCT02778893 | NSCLC | Conmana Thalidomide | 18 Years - 75 Years | Henan Provincial People's Hospital | |
| Thalidomide in Treating Patients With Extensive-Stage Small Cell Lung Cancer | NCT00053300 | Lung Cancer | thalidomide adjuvant therap... | 18 Years - | Case Comprehensive Cancer Center | |
| Study of Combination PS-341 and Thalidomide in Multiple Myeloma | NCT00083460 | Multiple Myelom... | PS-341 Thalidomide Dexamethasone | 18 Years - | University of Arkansas | |
| S0833, Bortezomib, Thalidomide, Lenalidomide, Combination Chemotherapy, and Autologous Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma | NCT01055301 | Multiple Myelom... Plasma Cell Mye... | bortezomib cisplatin cyclophosphamid... dexamethasone doxorubicin hyd... etoposide lenalidomide melphalan thalidomide gene expression... microarray anal... laboratory biom... autologous-auto... | 18 Years - 65 Years | SWOG Cancer Research Network | |
| Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors | NCT00165230 | Neuroendocrine ... | Thalidomide Temodar | 18 Years - | Dana-Farber Cancer Institute | |
| Thalidomide and Procarbazine in Treating Patients With Recurrent or Progressive Malignant Glioma | NCT00079092 | Brain and Centr... | procarbazine hy... thalidomide | 18 Years - 120 Years | Wake Forest University Health Sciences | |
| DCEP in Combination With Thalidomide as Salvage Therapy for Post Transplantation Relapse | NCT00083681 | Multiple Myelom... | Thalidomide Dexamethasone Cytoxan Etoposide Cisplatin G-CSF | 18 Years - | University of Arkansas |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
